References
- Montin D, Marolda A, Licciardi F, et al. Immunophenotype anomalies
predict the development of autoimmune cytopenia in 22q11.2 deletion
syndrome. J Allergy Clin Immunol Pract . 2019;7(7):2369-2376.
doi:10.1016/j.jaip.2019.03.014
- DePiero AD, Lourie EM, Berman BW, Robin NH, Zinn AB, Hostoffer RW.
Recurrent immune cytopenias in two patients with
DiGeorge/velocardiofacial syndrome. J Pediatr .
1997;131(3):484-486. doi:10.1016/s0022-3476(97)80085-6
- Mustillo PJ, Sullivan KE, Chinn IK, et al. Clinical practice
guidelines for the immunological management of chromosome 22q11.2
deletion syndrome and other defects in thymic development. J
Clin Immunol . 2023;43(2):247-270. doi:10.1007/s10875-022-01418-y
- Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. Autoimmune
cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol .
2003;25(3):195-197. doi:10.1046/j.1365-2257.2003.00508.x
- Lambert MP, Arulselvan A, Schott A, et al. The 22q11.2 deletion
syndrome: Cancer predisposition, platelet abnormalities and
cytopenias. Am J Med Genet A . 2018;176(10):2121-2127.
doi:10.1002/ajmg.a.38474
- Deshpande DR, Demirdag YY, Marsh RA, Sullivan KE, Orange JS, USIDNET
Consortium. Relationship Between Severity of T Cell Lymphopenia and
Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2
Deletions and/or Related TBX1 Mutations): a USIDNET Study. J
Clin Immunol . 2021;41(1):29-37. doi:10.1007/s10875-020-00854-y
- Giardino G, Radwan N, Koletsi P, et al. Clinical and immunological
features in a cohort of patients with partial DiGeorge syndrome
followed at a single center. Blood . 2019;133(24):2586-2596.
doi:10.1182/blood.2018885244
- Saco T, Geier C, Buchbinder D, et al. Are we diagnosing too late? RAG
deficiency in young adults with end organ damage. Journal of
Allergy and Clinical Immunology . 2021;147(2):AB69.
doi:10.1016/j.jaci.2020.12.270